Search

everythinglearnresearchcommunity

for

Search:↓

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Enhancing immune response can improve cancer treatment effectiveness.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

The peptide IMT-P8 can effectively deliver proteins into the skin and cells for potential skin treatments.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.